# FDA Inspection 1051475 - Ascension Borgess Hospital - March 02, 2018

Source: https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/12380088-127c-4375-9513-42c2b4c521a0
Source feed: FDA_Inspections

> FDA Inspection 1051475 for Ascension Borgess Hospital on March 02, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1051475
- Company Name: Ascension Borgess Hospital
- Inspection Date: 2018-03-02
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1180039 - 2022-08-26](https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/bf1aa30a-600e-4dd1-ac65-379111b21122)
- [FDA Inspection 1180039 - 2022-08-26](https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/a14fb864-3add-4778-ba4e-b056784381d6)
- [FDA Inspection 972724 - 2016-03-23](https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/f06ef8bc-d2b2-4553-a0ad-3bfce950492e)
- [FDA Inspection 868329 - 2014-02-13](https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/3c8f0718-dbf5-4c95-81db-355c077ac4c7)
- [FDA Inspection 761843 - 2012-01-04](https://www.keypedia.com/records/fda_inspections/ascension-borgess-hospital/a79d9c25-952d-4d92-84ca-f7c9f3bb6067)

Company: https://www.keypedia.com/companies/ascension-borgess-hospital/0dda645c-6a12-499f-b3c5-531373373c3b

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d